Latest in Pharma Sacklers
Sort by
11 items
-
Sacklers Up Their Offer to Settle Purdue Opioids Cases, With a New Condition
A group of 15 states have reached a tentative new deal that would require them to set aside hundreds of millions of dollars from the settlement in a legal-defense fund for the family.The New York Times - 16h -
Purdue and Sackler family agree to $7.4bn opioid settlement with US states
New deal is $1.4bn higher than previous one struck down by Supreme Court last yearFinancial Times - 15h -
Purdue Pharma, Sacklers reach new settlement agreement in opioid cases
Purdue Pharma and the members of the Sackler family who own the company agreed in principle to pay a $7.4 billion settlement to resolve thousands of lawsuits over their alleged role in the opioid ...The Hill - 16h -
Purdue Pharma, Sackler family to pay $7.4 billion opioid settlement
Purdue Pharma, the manufacturers of OxyContin, and members of the family that own the company, will pay billions to victims of the opioid crisis, as well as state and local governments.NBC News - 17h -
Purdue Pharma and Sackler family to pay $7.4 billion in OxyContin settlement
Members of the Sackler family, who own OxyContin maker Purdue Pharma, and the company itself agreed to pay up to $7.4 billion in a settlement to lawsuits over the toll of the opioid painkiller.NBC News - 18h -
Purdue Pharma and Sacklers reach new $7.4bn settlement over opioids crisis
Settlement resolves thousands of lawsuits alleging Oxycontin caused addiction crisis. The Sackler family, which owns the OxyContin maker Purdue Pharma, has agreed to pay up to $7.4bn in a ...The Guardian - 18h -
Sacklers, Purdue Pharma reach $7.4B settlement with 15 states over opioid crisis
The Sackler family will pay the vast majority of the settlement — a total of $6.5 billion over 15 years.CBS News - 18h -
Sacklers, Purdue Pharma reach $7.4 billion settlement in opioid lawsuits
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.ABC News - 19h -
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and Goliath dynamic” in 2024, report says.CNBC - 2d -
Bain Capital in Talks to Buy Mitsubishi Tanabe Pharma
Bain Capital is in talks to acquire Mitsubishi Chemical Group’s pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said.The Wall Street Journal - 3d -
Pharma giant seeks to join lawsuit against FDA over weight loss drugs
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the "entitlement" some ...The Hill - Jan. 2
